afliberceptum 2 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, natrii chloridum, saccharum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 50 µl corresp. natrium 60 µg.
Packungsbestandteile
Lösung zur intravitrealen Injektion in einer Fertigspritze
Active Agent
Dose
Afliberceptum
2mg / 50µl
BAG: Active Agent
Dose
Afliberceptum
2 mg
Inactive agents
Disodium Phosphate Heptahydrate
Sodium Chloride
Sodium Dihydrogenophosphate Monohydrate
Polysorbatum 20
Saccharum
Source
Data was imported : 04.12.2014
Swissmedic Registration : 62393
Sequence : 01
Product name : Eylea, Lösung zur intravitrealen Injektion in einer Fertigspritze
Registration owner: : Bayer (Schweiz) AG
Product group :
Index Therapeuticus (BSV) : 11.99.0.
Medication Code : Biotechnologika
Date of registration : 29.10.2012
Valid until : 28.10.2017
Package number : 001
Show package size : 1
Commercial Form/Unit : Spritze(n)
Swissmedic categorie. : B
Active Agents : afliberceptum
Composition : afliberceptum 2 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, natrii chloridum, saccharum, polysorbatum 20, aqua ad iniectabilia q.s. ad solutionem pro 50 µl.
